MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-07-2024
BIOLASE EV - Enterprise Value 2011-2026 | BIOL
Annual EV - Enterprise Value BIOLASE
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26.8 M | 29.1 M | 447 K | 82.2 M | 39.8 M | 58.1 M | 33.1 M | 107 M | 63.9 M | 101 M | 107 M | 104 M | 113 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 113 M | 447 K | 66.5 M |
EV - Enterprise Value of other stocks in the Medical devices industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aziyo Biologics
AZYO
|
89.6 M | - | 1.37 % | $ 20.5 M |  USA |
 |
Bruker Corporation
BRKR
|
3.81 B | $ 39.15 | -0.32 % | $ 5.83 K | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
76.6 M | - | - | $ 1.77 B | USA |
 |
Conformis
CFMS
|
3.84 M | - | - | $ 16.4 M | USA |
 |
Lianluo Smart Limited
LLIT
|
655 M | - | 24.59 % | $ 44.8 M |  China |
 |
Cardiovascular Systems
CSII
|
595 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
421 M | - | -10.19 % | $ 1.99 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-5.83 M | - | -5.86 % | $ 30.6 M | USA |
 |
Acutus Medical
AFIB
|
40.9 M | - | -26.83 % | $ 2.62 M | USA |
 |
Dynatronics Corporation
DYNT
|
13.8 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-53 M | - | - | $ 10.2 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
994 M | $ 8.07 | 3.2 % | $ 579 M |  Israel |
 |
Allied Healthcare Products
AHPI
|
696 K | - | 3.58 % | $ 2.21 M | USA |
 |
Second Sight Medical Products
EYES
|
5.82 M | - | -0.97 % | $ 54.4 M | USA |
 |
EDAP TMS S.A.
EDAP
|
252 M | $ 4.27 | 7.02 % | $ 159 M |  France |
 |
Electromed
ELMD
|
170 M | $ 24.2 | 0.92 % | $ 205 M | USA |
 |
AdaptHealth Corp.
AHCO
|
3.89 B | $ 9.66 | 2.87 % | $ 1.31 B | USA |
 |
FONAR Corporation
FONR
|
91.5 M | $ 18.55 | 0.24 % | $ 122 M | USA |
 |
Apollo Endosurgery
APEN
|
423 M | - | - | $ 475 M | USA |
 |
CONMED Corporation
CNMD
|
2.57 B | $ 43.23 | -0.41 % | $ 1.34 B | USA |
 |
CryoLife, Inc.
CRY
|
70.4 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
17.3 M | - | -20.74 % | $ 369 K | USA |
 |
CHF Solutions, Inc.
CHFS
|
-7.7 M | - | 1.15 % | $ 34.5 M | USA |
 |
AxoGen
AXGN
|
1.55 B | $ 29.56 | -0.91 % | $ 1.36 B | USA |
 |
Apyx Medical Corporation
APYX
|
54.4 M | $ 3.27 | 3.15 % | $ 113 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.67 B | - | - | $ 3.31 B | USA |
 |
InMode Ltd.
INMD
|
3.99 B | $ 13.54 | -0.44 % | $ 875 M | Israel |
 |
IRIDEX Corporation
IRIX
|
65.9 M | $ 1.42 | -0.7 % | $ 22.9 M | USA |
 |
IRadimed Corporation
IRMD
|
629 M | $ 105.47 | 1.13 % | $ 1.34 B | USA |
 |
Soliton, Inc.
SOLY
|
-100 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.54 B | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
427 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Accuray Incorporated
ARAY
|
492 M | $ 0.52 | -1.62 % | $ 53.4 M | USA |
 |
Misonix, Inc.
MSON
|
-1.79 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
639 M | - | - | $ 111 M |  Canada |
 |
Medigus Ltd.
MDGS
|
11.2 M | - | 10.28 % | $ 55.5 M | Israel |
 |
LivaNova PLC
LIVN
|
4.58 B | $ 67.45 | -1.43 % | $ 3.68 B |  Britain |
 |
Pulmonx Corporation
LUNG
|
347 M | $ 1.5 | -2.29 % | $ 58.7 M | USA |
 |
Cytosorbents Corporation
CTSO
|
87.4 M | $ 0.8 | -0.01 % | $ 43.5 M | USA |
 |
Align Technology
ALGN
|
15.2 B | $ 182.98 | 0.19 % | $ 13.7 B | USA |
 |
Medtronic PLC
MDT
|
152 B | $ 96.43 | -0.31 % | $ 124 B | USA |
 |
Intersect ENT, Inc.
XENT
|
1.02 B | - | - | $ 955 M | USA |
 |
Inari Medical
NARI
|
3.1 B | - | - | $ 4.23 B | USA |
 |
Butterfly Network
BFLY
|
765 M | $ 3.94 | 7.07 % | $ 834 M | USA |
 |
Abbott Laboratories
ABT
|
187 B | $ 113.75 | 0.11 % | $ 198 B | USA |
 |
NuVasive
NUVA
|
2.04 B | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
441 M | - | - | $ 217 M | USA |
 |
BioSig Technologies
BSGM
|
9.42 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
111 B | $ 73.16 | -0.93 % | $ 108 B | USA |